xMAP® Technology is a bead-based multiplexing platform that enables rapid detection of up to 500 analytes, including proteins or nucleic acids, from a small sample volume. The technology's sensitivity makes it ideal for complex serological applications. Luminex’s Partners have developed > 100 FDA 510(k)-cleared assays using xMAP Technology.
Visit Luminex at Diasorin Booth #1431 to learn how you can collaborate with Luminex to develop your assays!
Long Description
xMAP® Technology is a bead-based multiplexing platform that enables rapid detection of up to 500 analytes, including proteins or nucleic acids, from a small sample volume. The technology's sensitivity makes it ideal for complex serological applications.
Luminex’s Partners have developed > 100 FDA 510(k)-cleared assays using xMAP Technology.
Compared to ELISA, xMAP can shorten time to results, minimize the volume of sample required, and reduce labor by replacing multiple ELISAs with a single xMAP assay.
xMAP is used in various diagnostic applications, including:
• Genetically inherited disease screening
• HLA typing and antibody testing for transplantation
• Autoimmune disease profiling
• Early cancer detection
Luminex supports partners from concept to commercialization quickly through its unique expertise, end–to–end support, and access to thousands of labs using xMAP.
Visit Luminex at Diasorin Booth #1431 to explore how you can collaborate with Luminex to accelerate your ass
High Resolution Image
Small Image
Large Image
Category Product Showcase